NCT00055601 Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer Status COMPLETED Phase PHASE2
NCT00054626 Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer Status UNKNOWN Phase PHASE3
NCT00053209 Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium Status COMPLETED Phase PHASE2
NCT00052637 Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer Status COMPLETED Phase PHASE3
NCT00047216 Tipifarnib in Treating Patients With Recurrent Bladder Cancer Status COMPLETED Phase PHASE2
NCT00045630 S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium Status COMPLETED Phase PHASE2
NCT00042887 Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer Status TERMINATED Phase PHASE3
NCT00033436 Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer Status COMPLETED Phase PHASE3
NCT00028860 Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer Status COMPLETED Phase PHASE2
NCT00026884 Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease Status RECRUITING Phase N/A
NCT00024349 Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer Status COMPLETED Phase PHASE3
NCT00023842 BCG With or Without Mitomycin in Treating Patients With Bladder Cancer Status COMPLETED Phase PHASE2
NCT00022633 S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract Status TERMINATED Phase PHASE2
NCT00022191 Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer Status COMPLETED Phase PHASE3
NCT00019435 LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00016237 Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment Status COMPLETED Phase PHASE1
NCT00014534 Combination Chemotherapy in Treating Patients With Bladder Cancer Status COMPLETED Phase PHASE3
NCT00014456 Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00014287 Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer Status WITHDRAWN Phase PHASE1
NCT00014274 Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium Status COMPLETED Phase PHASE2/PHASE3